NASDAQ:ENDP Endo International (ENDP) Stock Price, News & Analysis Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$0.28▼$0.7552-Week Range N/AVolume9,967 shsAverage Volume28.19 million shsMarket Capitalization$141,000.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisHeadlinesSustainabilityTrendsStock AnalysisHeadlinesSustainabilityTrends Get Endo International alerts: Email Address Endo International MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestN/ADividend StrengthN/ASustainability-2.62Upright™ Environmental ScoreNews Sentiment0.01Based on 4 Articles This WeekInsider TradingN/AProj. Earnings Growth-83.33%From $0.78 to $0.13 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.13 out of 5 stars N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Endo International.Read more about Endo International's stock forecast and price target. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for ENDP. Previous Next 0.0 Dividend Strength Dividend YieldEndo International does not currently pay a dividend.Dividend GrowthEndo International does not have a long track record of dividend growth. Previous Next 3.5 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreEndo International has received a 40.36% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Frovatriptan succinate", "Other cancer medication", "Isosorbide dinitrate", "Oxycodone", "Cyanocobalamin", and "Paracetamol" products. See details.Environmental SustainabilityThe Environmental Impact score for Endo International is -2.62. Previous Next 1.1 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 4 news articles for Endo International this week, compared to 1 article on an average week.Search Interest20 people have searched for ENDP on MarketBeat in the last 30 days. This is an increase of 1,900% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Endo International insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.20% of the stock of Endo International is held by insiders.Percentage Held by Institutions80.39% of the stock of Endo International is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Endo International's insider trading history. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Endo International are expected to decrease by -83.33% in the coming year, from $0.78 to $0.13 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Endo International is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Endo International is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. About Endo International Stock (NASDAQ:ENDP)Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; AVEED to treat hypogonadism; QWO, an injectable treatment for moderate to severe cellulite in the buttocks of adult women; PERCOCET to treat moderate-to-moderately-severe pain; TESTOPEL an implantable pellet indicated for TRT in conditions associated with a deficiency or absence of endogenous testosterone; EDEX to treat erectile dysfunction; LIDODERM a topical patch product containing lidocaine for the relief of pain; and products for the pain management and urology. The company's Sterile Injectables segment manufactures VASOSTRICT, a vasopressin injection; ADRENALIN, a non-selective adrenergic agonist; and APLISOL, which is a sterile aqueous solution, as well as generic sterile injectable products, including ertapenem for injections and ephedrine sulfate injections. Its Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic products, and sprays. The company's International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women's health, oncology, and transplantation. The company sells its branded pharmaceuticals and generics to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.Read More Ad Porter & CompanyWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. ENDP Stock News HeadlinesSeptember 11, 2024 | benzinga.comTrump Vs. Harris: 2024 Election Betting Odds Show 'Love Story' For Vice President After Debate, Taylor Swift EndorsementSeptember 11, 2024 | benzinga.comTaylor Swift's Endorsement Of Kamala Harris Drives Over 330K Visitors To Vote.GovSeptember 16, 2024 | Crypto 101 Media (Ad)This Crypto Coin Could 10x FASTER Than BitcoinA shocking leak has revealed Japanese electronics giant Sony is now starting its own blockchain. This move is being made in preparation to onboard all of Sony products (including Sony's Playstation, which captured a record 62% share of the global gaming console market in 2024). Enthusiasts and experts are buzzing with anticipation qnd one little-known crypto coin is poised for RAPID growth as we see this all unfold.September 11, 2024 | financialpost.comTaylor Swift Endorses Harris for President After DebateSeptember 10, 2024 | benzinga.comTaylor Swift Endorsed Biden And Harris In 2020 — Will She Back Vice President Again In Final Stretch Of 2024 Election?September 7, 2024 | bitcoinist.comVC Blasts Ethereum and Layer-2s, Endorses Dash: Here’s WhySeptember 6, 2024 | msn.comJapan's Endo vows to fight for Liverpool placeSeptember 4, 2024 | reuters.comJapan must focus on positives ahead of World Cup qualifiers, Endo saysSeptember 16, 2024 | Crypto 101 Media (Ad)This Crypto Coin Could 10x FASTER Than BitcoinA shocking leak has revealed Japanese electronics giant Sony is now starting its own blockchain. This move is being made in preparation to onboard all of Sony products (including Sony's Playstation, which captured a record 62% share of the global gaming console market in 2024). Enthusiasts and experts are buzzing with anticipation qnd one little-known crypto coin is poised for RAPID growth as we see this all unfold.September 1, 2024 | msn.comEndo, Inc. Reports Strong Second-Quarter 2024 Financial PerformanceAugust 31, 2024 | investorplace.comNo Endorsements Will Prevent This Election ShockAugust 28, 2024 | bizjournals.comEndo parts ways with CEO four months after emerging from bankruptcyAugust 28, 2024 | seekingalpha.comEndo International plc (ENDPQ) Q2 2024 Earnings Call TranscriptAugust 25, 2024 | msn.comAmbassador Endo sends off the 22nd Batch of JDS FellowsAugust 24, 2024 | benzinga.comTrump Welcomes RFK Jr. At Arizona Rally Following Endorsement, Calls Him An 'Incredible Champion:' 'I Think He's Going To Have A Huge Influence On This Campaign'August 24, 2024 | insidebitcoins.comSuper Trump Price Prediction: STRUMP Surges 17% After RFK Jr Endorsement And This PEPE 2.0 Presale Rockets Towards $11MAugust 23, 2024 | benzinga.comKennedy Family Members Condemn RFK Jr.'s Trump Endorsement As 'Betrayal,' Throw Their Weight Behind Harris And Walz: 'Sad Ending To A Sad Story'August 16, 2024 | msn.comWataru Endo: Why Liverpool are signing the midfielder and everything you need to know about himSee More Headlines Receive ENDP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Endo International and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/04/2021Today9/15/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryPharmaceuticals Current SymbolNASDAQ:ENDP CUSIP29264F20 CIK1593034 Webwww.endo.com Phone(531) 268-2000Fax800-329-3636Employees3,103Year Founded1997Profitability EPS (Most Recent Fiscal Year)($11.07) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-613,240,000.00 Net Margins-93.31% Pretax Margin-91.14% Return on Equity-34.25% Return on Assets6.72% Debt Debt-to-Equity RatioN/A Current Ratio1.86 Quick Ratio1.62 Sales & Book Value Annual Sales$2.99 billion Price / Sales0.00 Cash FlowN/A Price / Cash Flow0.06 Book Value($13.60) per share Price / BookN/AMiscellaneous Outstanding Shares235,143,000Free Float232,321,000Market Cap$141,000.00 OptionableNo Data Beta1.15 Social Links Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Blaise A. Coleman (Age 48)Pres, CEO & Director Comp: $20.93MMr. Mark T. Bradley (Age 52)Exec. VP & CFO Comp: $6.27MMr. Matthew Joseph Maletta (Age 50)Exec. VP, Chief Legal Officer & Company Sec. Comp: $7.02MMr. Patrick A. Barry (Age 54)Exec. VP & Pres of Global Commercial Operations Comp: $6.15MFrank B. RacitiVP, Controller & Chief Accounting OfficerMs. Cheryl StouchSr. VP of Information Technology & Chief Information OfficerMs. Laure E. ParkSr. VP of Investor Relations & Corp. AffairsMs. Susan WilliamsonSr. VP & Chief Compliance OfficerMs. Tracy BassoChief HR OfficerMr. James PappHead of Endo Ventures Limited & Sr. VP of Global Supply ChainMore ExecutivesKey CompetitorsAthenexNASDAQ:ATNXRepare TherapeuticsNASDAQ:RPTXMacroGenicsNASDAQ:MGNXEpizymeNASDAQ:EPZMCOMPASS PathwaysNASDAQ:CMPSView All Competitors ENDP Stock Analysis - Frequently Asked Questions How were Endo International's earnings last quarter? Endo International plc (NASDAQ:ENDP) issued its quarterly earnings data on Thursday, November, 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.46 by $0.34. The company's quarterly revenue was up 21.6% on a year-over-year basis. What other stocks do shareholders of Endo International own? Based on aggregate information from My MarketBeat watchlists, some other companies that Endo International investors own include Teva Pharmaceutical Industries (TEVA), Bausch Health Companies (BHC), Mallinckrodt (MNK), Gilead Sciences (GILD), TherapeuticsMD (TXMD), Micron Technology (MU) and Cleveland-Cliffs (CLF). This page (NASDAQ:ENDP) was last updated on 9/16/2024 by MarketBeat.com Staff From Our PartnersMore Than 30 Federal Agencies Buy From This Cybersecurity TechIn January of 2022 Ukraine was hit by an especially nasty piece of malware, named WhisperGate. By then Ukra...Capital Trends | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Turn Smartphones Into “Earnphones”?High-Growth Smartphone Startup 45 Million Users. $60M+ in Revenue. 32,481% Growth Rate. $1T+ market opportu...Mode Mobile | SponsoredGrab this ETF paying a huge 22% dividendLet's do a little math here... To double your money at a 3% rate of return, you would need around 23 years....Investors Alley | SponsoredWhy Institutions Are Bullish on BitcoinThe recent dip in the crypto market might be stressful… But it also presents a tremendous opportunity for s...Crypto 101 Media | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Endo International plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Endo International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.